Satellos Bioscience Inc. Satellos Bioscience Inc.

Satellos Bioscience Inc.

MSCL

Rank in Stocks #18108
Satellos Bioscience Inc., a biotechnology firm established in 2018 and... Satellos Bioscience Inc., a biotechnology firm established in 2018 and headquartered in Toronto, Canada, specializes in developing regenerative therapies for degenerative muscle diseases. The company primarily operates in Canada and Australia, utilizing its proprietary MyoReGenX platform – an automated microscopy system engineered to replicate the muscle stem cell environment outside the body. A key focus for Satellos is the discovery and development of a small molecule drug specifically aimed at treating Duchenne muscular dystrophy.
Share Price
$6.66
Last synced: 2026-11-13
Market Cap
$141.04M
Change (1 day)
-0.85%
Change (1 year)
8.63%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
EPS for Satellos Bioscience Inc. (MSCL)
EPS as of September 2026 TTM: $-2.10
According to Satellos Bioscience Inc.'s latest financial reports, its current EPS (TTM) is $-2.10. At the end of 2025 the company had an EPS of $-1.73, an increase over its 2024 EPS of $-2.05.
EPS history for Satellos Bioscience Inc. from 2007 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-2.10 21.39%
2025 $-1.73 -15.56%
2024 $-2.05 22.83%
2023 $-1.67 -40.60%
2022 $-2.81 -54.09%
2021 $-6.12 1,242.38%
2020 $-0.46 -18.83%
2019 $-0.56 -84.24%
2018 $-3.56 86.58%
2017 $-1.91 -46.62%
2016 $-3.57 3.52%
2015 $-3.45 -16.40%
2014 $-4.13 -79.68%
2013 $-20.33 20.30%
2012 $-16.90 259.58%
2011 $-4.70 -75.57%
2010 $-19.23 5.29%
2009 $-18.27 -33.66%
2008 $-27.54 -90.12%
2007 $-278.66 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$-0.89 -57.62%
US
$15.66 -845.71%
US
$-7.07 236.67%
US
$-5.29 151.90%
AU
$12.73 -706.30%
BE

Questions about Satellos Bioscience Inc.'s earnings per share (EPS)

What is Satellos Bioscience Inc.'s earnings per share (EPS)?

Satellos Bioscience Inc.'s earnings per share (EPS) over the last twelve months is $-2.10, as of Sep 2026.

What was Satellos Bioscience Inc.'s earnings per share (EPS) in 2025?

In 2025, Satellos Bioscience Inc.'s earnings per share (EPS) was $-1.73, compared with $-2.05 in 2024.

How has Satellos Bioscience Inc.'s earnings per share (EPS) changed since 2020?

From 2020 to 2025, Satellos Bioscience Inc.'s earnings per share (EPS) was highest in 2020 ($-0.46) and lowest in 2021 ($-6.12).

How does Satellos Bioscience Inc.'s earnings per share (EPS) compare with similar companies?

Satellos Bioscience Inc.'s earnings per share (EPS) ($-2.10) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.